Specific transduction of HIV-1 envelope expressing cells by retroviral vectors pseudotyped with hybrid CD4/CXCR4 receptors

• Published in: Journal of virological methods 2002-06, Vol.104 (1), p.83-92
• Main Authors: Bittner, Alexandra, Mitnacht-Kraus, Rita, Schnierle, Barbara S.
• Format: Article
• Language: English
• Subjects: Biological and medical sciences; Biotechnology; CD4; CD4 Antigens - genetics; Cell Line, Transformed; CXCR4; Envelope; Fundamental and applied biological sciences. Psychology; Fusion Proteins, gag-pol - genetics; Gene Products, rev - genetics; Gene therapy; Genetic Vectors - genetics; Health. Pharmaceutical industry; HIV-1 - genetics; Humans; Industrial applications and implications. Economical aspects; Lentivirus - genetics; Leukemia Virus, Murine - genetics; Receptors, CXCR4 - genetics; Recombinant Fusion Proteins - genetics; Retroviral vectors; rev Gene Products, Human Immunodeficiency Virus; Transduction, Genetic
• ISSN: 0166-0934; 1879-0984
• DOI: 10.1016/S0166-0934(02)00043-5

Infection of a target cell by HIV is initiated by the interaction of the envelope glycoprotein with the CD4 receptor molecule on the surface of the target cell. This is followed by binding of a coreceptor of the chemokine receptor family and subsequently fusion of viral and cellular membranes. Membrane fusion is independent of whether the viral envelope protein is on the viral or on the cellular membrane. Accordingly, targeting of HIV infected cells by retroviral vectors has been previously achieved both by coincorporation of CD4 and coreceptors into murine leukemia virus (MLV) and lentivirus based vector particles. It was, therefore, tested whether hybrid genes of CD4 and CXCR4 are also able to yield ‘receptor’ vectors. A construct containing the four extracellular loops of CD4 fused to CXCR4 (CD4-D4-X4) allowed gene transfer into HIV-1 envelope expressing cells by vectors based on either MLV or lentiviruses. The CD4-D2-X4 hybrid receptor, containing the first two extracellular CD4 domains, allowed gene transfer only by lentiviral vectors. Attempts to increase vector titres by deletion of the intracellular part of CXCR4 failed. Vector titres obtained by hybrid receptors were slightly lower than published titres obtained by separate expression of CD4 and CXCR4. Thus, CD4-D4-CXCR4 hybrids are useful for the generation of retroviral and lentiviral vectors with specificity for HIV-1 envelope expressing cells.